219 results
8-K
EX-99.1
MDGL
Madrigal Pharmaceuticals, Inc.
7 Aug 24
Madrigal Pharmaceuticals Reports Second-Quarter 2024 Financial Results and Provides Corporate Updates
7:06am
to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, that are based on Madrigal’s beliefs and assumptions
8-K
EX-1.1
MDGL
Madrigal Pharmaceuticals, Inc.
7 May 24
Entry into a Material Definitive Agreement
4:36pm
Applicable Laws or Authorizations and has no knowledge that any such governmental authority or third party is considering any such claim, litigation
424B3
MDGL
Madrigal Pharmaceuticals, Inc.
7 May 24
Prospectus supplement
4:34pm
are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements other
424B5
MDGL
Madrigal Pharmaceuticals, Inc.
7 May 24
Prospectus supplement for primary offering
4:29pm
for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements other than statements … of our clinical trials;
public concern as to the safety and efficacy of products developed by us or others; and
litigation.
In addition, due to one
8-K
EX-99.1
hzwij1
7 May 24
Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
7:06am
8-K
abyb5ikx
20 Mar 24
Entry into a Material Definitive Agreement
4:11pm
424B5
31z0jzvef9x6wkh44
20 Mar 24
Prospectus supplement for primary offering
4:06pm
424B5
zmn3n
18 Mar 24
Prospectus supplement for primary offering
4:08pm
8-K
EX-99.1
uxwyaj48m5w7al00yyl
14 Mar 24
Regulation FD Disclosure
6:47pm
8-K
EX-99.2
nve9 no6j
14 Mar 24
Regulation FD Disclosure
6:47pm
8-K
EX-99.1
2r0d3e0bauaa4ifyjrs
28 Feb 24
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Fourth Quarter and Full
7:01am
8-K
EX-99.1
ss2ypebo
8 Jan 24
Other Events
1:45pm
8-K
EX-99.1
x1dbaguzf hqy0m3yjw
6 Nov 23
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Third Quarter 2023
8:31am